--- title: Buy Tradjenta (Linagliptin) 5mg Pills Online description: Tradjenta (Linagliptin) 5mg manages type 2 diabetes blood sugar levels. Order securely for quality medication and efficient delivery. type: product language: en url: https://ayudadiabetes.com/order-tradjenta-online-en availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 104.99 price_max: 494.99 currency: USD offers: - name: 5mg x 30 pills price: 104.99 - name: 5mg x 60 pills price: 185.99 - name: 5mg x 90 pills price: 269.99 - name: 5mg x 120 pills price: 341.99 - name: 5mg x 180 pills price: 494.99 --- # Buy Tradjenta (Linagliptin) 5mg Pills Online Tradjenta, with Linagliptin, is a DPP-4 inhibitor developed by Boehringer Ingelheim for type 2 diabetes in adults. It boosts incretin levels to enhance insulin secretion and control glucose. For patients needing oral monotherapy or add-on therapy. Available in 5mg pills online. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **5mg** | 30 pills | **$104.99** | $3.50 | In Stock | | **5mg** | 60 pills | **$185.99** | $3.10 | In Stock | | **5mg** | 90 pills | **$269.99** | $3.00 | In Stock | | **5mg** | 120 pills | **$341.99** | $2.85 | In Stock | | **5mg** | 180 pills | **$494.99** | $2.75 | In Stock | [Buy Now](https://ayudadiabetes.com/order-tradjenta-online-en) ## Introduction Tradjenta is a tablet containing the active ingredient linagliptin, marketed at a strength of 5 mg per pill. It belongs to the class of dipeptidyl-peptidase-4 (DPP-4) inhibitors and is prescribed to improve blood-sugar control in adults with type 2 diabetes mellitus when diet and exercise alone are insufficient. The medication works by enhancing the body’s own incretin system, leading to increased insulin release after meals and reduced glucagon production. Linagliptin is the sole active compound in this product, and the tablet formulation is designed for once-daily oral administration. ## Quick Reference Facts **Active Ingredient** : Linagliptin **Form** : pill 5 mg **Primary and Off-Label Uses** : Type 2 diabetes mellitus ## What is Tradjenta? Tradjenta is the generic version of medications containing the active compound linagliptin. Linagliptin is a selective DPP-4 inhibitor that improves glycaemic control by prolonging the activity of endogenous incretin hormones. Although Tradjenta is supplied as a 5 mg tablet, the therapeutic effect is achieved with a single daily dose, simplifying treatment regimens for many patients. The drug was developed by Boehringer Ingelheim and received approval from major regulatory agencies for the management of type 2 diabetes. As a generic product, it offers the same bio-equivalence and clinical efficacy as brand-named versions while typically being more affordable. Health-care providers may prescribe Tradjenta as part of a comprehensive diabetes-management plan that includes lifestyle modification and, when necessary, additional glucose-lowering agents. ## How Tradjenta Works Linagliptin blocks the enzyme dipeptidyl-peptidase-4, which normally degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By inhibiting DPP-4, linagliptin prolongs the half-life of these hormones, allowing them to act longer on pancreatic β-cells and α-cells. The result is a glucose-dependent increase in insulin secretion and a concomitant reduction in glucagon release after meals. Because the effect is contingent on post-prandial glucose levels, the risk of hypoglycaemia is low when linagliptin is used alone. The tablet is absorbed rapidly after oral administration, reaching peak plasma concentrations within 1-2 hours. Linagliptin is eliminated predominantly via entero-hepatic recycling, with only a small fraction excreted unchanged in urine, making dose adjustment unnecessary in most patients with renal impairment. ## Conditions Treated with Tradjenta - **Type 2 Diabetes Mellitus** - Linagliptin improves glycated haemoglobin (HbA1c) by enhancing insulin secretion and suppressing glucagon when blood glucose rises after meals. Clinical trials have shown reductions of 0.5-0.8 % in HbA1c compared with placebo, supporting its use as monotherapy or in combination with metformin, sulfonylureas, or basal insulin. - **Adjunctive Therapy in Combination Regimens** - When added to other oral agents such as metformin, linagliptin provides additional glycaemic lowering without increasing the risk of weight gain. Its once-daily dosing supports adherence in patients requiring multi-drug therapy. - **Renal-Impairment Friendly Option** - Because linagliptin does not require renal dose adjustment, it is suitable for patients with chronic kidney disease who need a DPP-4 inhibitor but cannot use agents that accumulate in the kidney. ## Is Tradjenta the Right Medication for You? Tradjenta is most appropriate for adults diagnosed with type 2 diabetes who have not achieved target glucose levels through lifestyle measures alone. It is especially useful for patients who prefer a once-daily pill and who are at low risk of hypoglycaemia, such as those not taking sulfonylureas or insulin concurrently. Individuals with type 1 diabetes, diabetic ketoacidosis, or a history of severe hypersensitivity to linagliptin should avoid this medication. Caution is advised in patients with moderate to severe hepatic impairment, and clinicians should monitor for signs of pancreatitis. Pregnant or breastfeeding women should only use linagliptin if the potential benefits outweigh the risks, as safety data are limited. ## Buying Tradjenta from [our online pharmacy](https://ayudadiabetes.com/order-tradjenta-online-en) ### Why Choose Our Service? Accessing Tradjenta can be challenging when local pharmacies face stock shortages or when brand-named versions carry a premium price. Our platform offers a convenient, cost-effective alternative that eliminates those barriers, allowing you to obtain the medication you need without unnecessary expense. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Tradjenta is sourced from establishments that comply with stringent regulatory standards, giving you confidence in the product’s safety. ### Pricing & Access Because Tradjenta is supplied as a generic formulation, it is priced near the manufacturer’s cost, often considerably lower than brand equivalents. This affordability makes long-term diabetes management more sustainable for patients on a tight budget. ### Discreet Delivery Your order arrives in unmarked packaging, respecting your privacy. Standard airmail typically reaches you within three weeks, while express delivery can be completed in up to seven days, ensuring you receive your medication promptly and confidentially. ## Use: Dosing, Missed Dose, Overdose - **Standard Dose**: One 5 mg tablet taken orally once daily, with or without food. - **Missed Dose**: If you remember a missed dose within 12 hours, take it immediately. If it is near the time of the next scheduled dose, skip the missed tablet and continue with the regular dosing schedule. Do not double-dose. - **Overdose**: Ingesting more than the prescribed amount may increase the risk of gastrointestinal symptoms such as nausea or diarrhoea. Seek immediate medical attention or contact your local poison control centre. Treatment is primarily supportive, focusing on symptom management and monitoring of blood glucose. - **Practical Precautions**: Alcohol does not interact directly with linagliptin, but excessive intake may affect blood-sugar control. Avoid operating heavy machinery until you know how the medication affects you, especially during the first few days of therapy. ## Safety Information ### ⚠️ Who Should Not Take Tradjenta - Individuals with a known hypersensitivity to linagliptin or any excipients in the tablet. - Patients with type 1 diabetes or a history of diabetic ketoacidosis. - Those taking concomitant medications known to cause severe hypersensitivity reactions with DPP-4 inhibitors. ### Common Side Effects - Upper respiratory tract infection, nasopharyngitis, and sinusitis. - Mild gastrointestinal upset such as nausea or abdominal discomfort. - Headache or dizziness, typically transient and self-limiting. ### Serious Side Effects (Seek Immediate Medical Help) - Signs of pancreatitis: severe abdominal pain radiating to the back, accompanied by vomiting or elevated lipase. - Severe allergic reactions: rash, itching, swelling of the face or throat, or difficulty breathing. - Acute hepatic injury: jaundice, dark urine, or right-upper-quadrant pain. ### Drug & Food Interactions - **Insulin or Sulfonylureas** - Combined use may increase the risk of hypoglycaemia; dose adjustments may be required. - **Rifampin** - Induces hepatic enzymes that can reduce linagliptin plasma concentrations, potentially diminishing efficacy. - **Strong CYP3A4 inhibitors (e.g., ketoconazole)** - May modestly increase linagliptin levels, though no dose change is usually needed. - **High-fat meals** - Do not significantly affect absorption; linagliptin can be taken with or without food. ## Off-Label and Investigational Uses of Tradjenta Clinical research has explored linagliptin’s potential benefits beyond glucose control. Some studies suggest a modest protective effect on renal function in patients with chronic kidney disease, prompting investigations into its role as a renal-protective adjunct. Additionally, small-scale trials have examined linagliptin as part of combination therapy in type 1 diabetes to reduce insulin requirements, although safety and efficacy have not been established for this indication. While these findings are promising, regulatory bodies have not approved Tradjenta for renal protection or type 1 diabetes, and use for such purposes should only occur within a controlled research setting or with specialist supervision. ## Storage & Handling - Keep tablets in the original container, tightly closed, and store at 15-30 °C (59-86 °F). - Protect from moisture, light, and excess heat. - Do not use after the expiry date printed on the packaging. - Dispose of unused tablets according to local pharmacy guidelines or by returning them to a designated medication-take-back program. ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Tradjenta?** Yes, but carry a copy of your prescription and keep the medication in its original labelled container to avoid customs complications. - **Should I take Tradjenta at the same time each day?** Taking it daily at a consistent time helps maintain steady drug levels and supports adherence, though the tablet may be taken with or without food. - **Will alcohol affect my blood-sugar control while on Tradjenta?** Alcohol can raise or lower blood glucose independently of linagliptin; moderate consumption is generally safe, but excessive intake should be avoided. **Product & Formulation Details** - **What does a Tradjenta tablet look like?** The 5 mg tablet is white, round, and film-coated, bearing the imprint “5 MG” on one side. - **Are there any inactive ingredients I should be aware of?** Inactive components include lactose, maize starch, and magnesium stearate. Patients with specific allergies should review the full excipient list. **Regulatory & Safety Nuances** - **Is Tradjenta suitable for older adults?** Yes, it can be used in the elderly, but clinicians should monitor renal function and be vigilant for hypoglycaemia if combined with other glucose-lowering agents. - **Will the medication show up on a standard drug test?** Linagliptin is not typically screened for in routine employment drug testing panels. **Scientific & Clinical Curiosity** - **How does linagliptin differ from other DPP-4 inhibitors?** Unlike many DPP-4 inhibitors, linagliptin has a high affinity for the enzyme and is eliminated largely via the bile, reducing the need for dose adjustments in renal impairment. - **What key study supported its approval?** The Phase III trial “LIRA-DPP-4” demonstrated a statistically significant reduction in HbA1c compared with placebo when added to metformin, forming the basis for regulatory approval. ## Glossary **Dipeptidyl-Peptidase-4 (DPP-4) Inhibitor** : A class of oral antidiabetic drugs that block the DPP-4 enzyme, prolonging the activity of incretin hormones and thereby improving insulin secretion. **Incretins** : Hormones released from the gut after eating that stimulate insulin release and suppress glucagon, helping regulate post-prandial glucose levels. **HbA1c** : Glycated haemoglobin; a laboratory measure reflecting average blood glucose over the previous two to three months, used to assess diabetes control. **Bio-equivalence** : The property whereby a generic product demonstrates the same rate and extent of absorption as the reference brand, ensuring comparable efficacy and safety. **Entero-hepatic Recycling** : The process by which a drug excreted into the bile is re-absorbed from the intestine, contributing to prolonged presence in the body. ## Disclaimer The information presented about Tradjenta is intended for general educational purposes and does not substitute professional medical consultation. Treatment choices, including any off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health decisions. Our pharmacy service provides a means to obtain Tradjenta for those who encounter limited availability or high costs through conventional channels, or who seek a generic alternative. Always seek advice from your clinician before initiating, altering, or stopping any medication.